Atlas Trials

Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular Degeneration

Clinical trial NCT05439629 · COMPLETED

Trial details

NCT number
NCT05439629
Sponsor
Bio-Thera Solutions
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Neovascular (Wet) Age-related Macular Degeneration
Start date
2022-07-07
Primary completion
2025-04-22
Enrollment
488

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.